BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2027.
World J Gastroenterol. Jan 14, 2027; 33(2): 127120
Published online Jan 14, 2027. doi: 10.3748/wjg.127120
Table 3 Comparison of clinical outcomes between interval and sporadic colorectal cancers, before and after propensity score weighting
Before PSW
After PSW
Interval CRC (n = 28)
Sporadic CRC (n = 79)
P value
SMD
Interval CRC (n = 23.60)
Sporadic CRC (n = 67.48)
P value
SMD
1st line treatment0.0110.7010.2500.401
Endoscopic treatment3 (10.7)1 (1.3)0.8 (3.3)0.7 (1.1)
Colectomy22 (78.6)73 (92.4)22.0 (93.3)63.0 (93.4)
Chemotherapy1 (3.6)1 (1.3)0.3 (1.1)0.8 (1.1)
Radiation therapy0 (0.0)4 (5.1)0 (0.0)3.0 (4.4)
Chemoradiation therapy2 (7.1)0 (0.0)0.5 (2.2)0 (0.0)
Stage0.0040.7910.1770.743
I13 (46.3)11 (13.9)10.2 (43.3)10.8 (16.1)
II8 (28.6)28 (35.4)7.4 (31.2)24.7 (36.6)
III5 (17.9)27 (34.2)5.5 (23.2)21.4 (31.7)
IV2 (7.1)13 (16.5)0.5 (2.3)10.6 (15.7)
DeathYes8 (28.6)22 (27.8)0.9420.6535.1 (21.4)17.9 (26.5)0.7150.119
Overall survivalMonths, mean 88.09 (53.88)61.25 (21.80)< 0.0010.65387.96 (41.20)61.17 (26.5)0.0320.813


Write to the Help Desk